- Anti-Bacterial
- Anti-Viral
- Anti-Parasite
- Anti-Fungal
- Others
Infectious Disease Therapeutics Market size valued USD 128.4 billion in 2022 and expected to reach USD 175.32 billion by 2029, at a CAGR of 7.8% during the forecast period 2023-2029. Infectious diseases are caused by organisms, such as bacteria, virus, fungi or parasites. Many organisms live in our body but few of them cause diseases. These infectious diseases are transmitted from one individual to other either by direct or indirect contact. The drugs used for infectious diseases are antibiotics, antiviral, and antiparasitic, among others. Infectious disease therapeutics acts directly on organisms or helps the body system to fight infections. Infectious diseases include HIV, malaria, tuberculosis, hepatitis, and influenza, among others. Market players focus on mergers, acquisitions and collaborations to increase revenue share in the market. For instance, in August 2016, Pfizer acquired AstraZeneca's late-stage small molecule anti-infectives business for development and commercialization outside the U.S. In addition, market players investing on research and development to introduce new drugs and to strengthen their position in the infectious disease therapeutics market. Some of the pipeline anti-infectives include avycaz (ceftazidime and avibactam), bictegravir (Anti HIV), cabotegravir (Anti HIV). Patent expiry of blockbuster anti-infectives such as Tamiflu, cubicin and ambisome are expected to negatively effect the infectious disease therapeutics market.
Infectious Disease Therapeutics Market Key Developments:
- In July 2017, Gilead's oral tablet was approved by U.S. FDA for treatment of adults with chronic hepatitis C virus
- In March 2015, U.S. Food and Drug Administration approved cresemba (isavuconazonium sulfate), a novel antifungal drug for treat adults with invasive aspergillosis and invasive mucormycosis, rare but serious infections
- In December 2014, Sanofi Pasteur announces FDA approval of fluzone intradermal quadrivalent (Influenza Vaccine) for adults.
Global Infectious Disease Therapeutics Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
7.8%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Infectious Disease Therapeutics Market Dynamics
Infectious disease therapeutics market is driven by the growing prevalence rates of infectious diseases, increased healthcare expenditure and increased funding of governments on prevention and management of infectious diseases. In addition, increased geriatric population and use of direct acting antiviral drugs are fuelling the growth of infectious diseases therapeutics market. However, patent expiry of many infectious disease drugs and increase number of generic alternatives hindering the market revenue of infectious disease therapeutics market.
North America Got Significant Share
Infectious Disease Therapeutics Market Regional Analysis
Geographically market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America dominates the infectious disease therapeutics market owing to high prevalence rates of infectious diseases and rise in ageing population. According to scientific data from Princeton University 2015, rising trend in consumption of anti-infectives has increased in BRICS nation. In the last few years, there was an increase in use of antibiotics in Asian countries like India and China and some parts of Africa. Factors such as rapidly developing healthcare infrastructure on the grounds of emerging medical tourism industry along with government initiative to boost biotechnology sector of the respective country are fuelling the growth of the infectious disease therapeutics market in Asia Pacific region.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Global Infectious Disease Therapeutics Market Segmentation
By Drug Class
By Disease Indication
- HIV/AIDS
- Influenza
- Hepatitis
- Malaria
- TB
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
Frequently Asked Questions
The infectious disease treatment market was expected to grow at a significant compound annual growth rate (CAGR) of 7.8% from 2023 to 2029. Additionally, it mentions that the market value was USD 128.4 billion in 2022.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
- Executive summary
- Global Infectious Disease Therapeutics Market Introduction
- Global Infectious Disease Therapeutics Market - Taxonomy
- Global Infectious Disease Therapeutics Market - Definitions
- Drug Class
- Disease Indication
- Global Infectious Disease Therapeutics Market Dynamics
- Drivers
- Restraints
- Opportunities/Unmet Needs of the Market
- Trends
- Global Infectious Disease Therapeutics Market Dynamics - Factors Impact Analysis
- Global Infectious Disease Therapeutics Market - Regulations
- US
- Europe
- Japan
- Global Infectious Disease Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year -over -Year (Y -o -Y) Growth Analysis (%)
- Market Oppurtunity Analysis
- Global Infectious Disease Therapeutics Market, By Drug Class, 2018 - 2022 and Forecast, 2023 - 2029
- Anti -Bacterial
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Anti -Viral
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Anti -Parasite
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Anti -Fungal
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Others
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Anti -Bacterial
- Global Infectious Disease Therapeutics Market Forecast, By Disease Indication, 2018 - 2022 and Forecast, 2023 - 2029
- HIV/AIDS
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Influenza
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Hepatitis
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Malaria
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Tuberculosis (TB)
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Others
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- HIV/AIDS
- Global Infectious Disease Therapeutics Market Forecast, By Distribution Channel, 2018 - 2022 and Forecast, 2023 - 2029
- Hospital Pharmacies
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Retail Pharmacies
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Online Pharmacies
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Hospital Pharmacies
- Global Infectious Disease Therapeutics Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029
- North America
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Europe
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Asia -Pacific
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Latin America
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Middle East and Africa
- Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
- Year -over -Year (Y -o -Y) Growth Analysis (%) and Market Share Analysis (%)
- Market Opportunity Analysis
- Global Infectious Disease Therapeutics Market - Opportunity Analysis Index - By Drug Class, By Disease Indication, By Distribution Channel, and Region, 2023 - 2029
- North America
- North America Infectious Disease Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
- Drug Class Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%), and Market Share (%)
- Anti -Bacterial
- Anti -Viral
- Anti -Parasite
- Anti -Fungal
- Others
- Disease Indication Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%) and Market Share (%)
- HIV/AIDS
- Influenza
- Hepatitis
- Malaria
- TB
- Others
- Distribution Channel Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%) and Market Share (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y -o -Y Growth (%) and Market Share (%)
- S.
- Canada
- North America Infectious Disease Therapeutics Market - Opportunity Analysis Index - By Drug Class, By Disease Indication, By Distribution Channel, and Country, 2023 - 2029
- North America Infectious Disease Therapeutics Market Dynamics - Trends
- Drug Class Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%), and Market Share (%)
- Europe Infectious Disease Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
- Drug Class Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%), and Market Share (%)
- Anti -Bacterial
- Anti -Viral
- Anti -Parasite
- Anti -Fungal
- Others
- Disease Indication Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%) and Market Share (%)
- HIV/AIDS
- Influenza
- Hepatitis
- Malaria
- TB
- Others
- Distribution Channel Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%) and Market Share (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%) and Market Share (%)
- Germany
- UK
- France
- Spain
- Italy
- Russia
- Poland
- Rest of Europe
- Europe Infectious Disease Therapeutics Market - Opportunity Analysis Index - By Drug Class, By Disease Indication, By Distribution Channel, and Country, 2023 - 2029
- Europe Infectious Disease Therapeutics Market Dynamics - Trends
- Drug Class Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%), and Market Share (%)
- Asia -Pacific Infectious Disease Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
- Drug Class Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%), and Market Share (%)
- Anti -Bacterial
- Anti -Viral
- Anti -Parasite
- Anti -Fungal
- Others
- Disease Indication Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%) and Market Share (%)
- HIV/AIDS
- Influenza
- Hepatitis
- Malaria
- TB
- Others
- Distribution Channel Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%) and Market Share (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn),
- Drug Class Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%), and Market Share (%)
- Y -o -Y Growth (%), and Market Share (%)
- Japan
- China
- India
- ASEAN
- Australia & New Zealand
- Rest of Asia -Pacific
- Asia -Pacific Infectious Disease Therapeutics Market - Opportunity Analysis Index - By Drug Class, By Disease Indication, By Distribution Channel, and Country, 2023 - 2029
- Asia -Pacific Infectious Disease Therapeutics Market Dynamics - Trends
- Latin America Infectious Disease Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
- Drug Class Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%), and Market Share (%)
- Anti -Bacterial
- Anti -Viral
- Anti -Parasite
- Anti -Fungal
- Others
- Disease Indication Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%) and Market Share (%)
- HIV/AIDS
- Influenza
- Hepatitis
- Malaria
- TB
- Others
- Distribution Channel Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%) and Market Share (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%) and Market Share (%)
- Brazil
- Mexico
- Argentina
- Venezuela
- Rest of Latin America
- Latin America Infectious Disease Therapeutics Market - Opportunity Analysis Index - By Drug Class, By Disease Indication, By Distribution Channel, and Country, 2023 - 2029
- Latin America Infectious Disease Therapeutics Market Dynamics - Trends
- Drug Class Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%), and Market Share (%)
- Middle East & Africa Infectious Disease Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
- Drug Class Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%), and Market Share (%)
- Anti -Bacterial
- Anti -Viral
- Anti -Parasite
- Anti -Fungal
- Others
- Disease Indication Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%) and Market Share (%)
- HIV/AIDS
- Influenza
- Hepatitis
- Malaria
- TB
- Others
- Distribution Channel Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%) and Market Share (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%), and Market Share (%)
- Gulf Cooperation Council (GCC) Countries
- Israel
- South Africa
- Rest of MEA
- MEA Infectious Disease Therapeutics Market - Opportunity Analysis Index - By Drug Class, By Disease Indication, By Distribution Channel, and Country, 2023 - 2029
- MEA Infectious Disease Therapeutics Market Dynamics - Trends
- Drug Class Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y -o -Y Growth (%), and Market Share (%)
- Competition Landscape
- Strategic Dashboard of Top Market Players
- Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
- GlaxoSmithKline Plc (U.K.)
- Johnson & Johnson Services, Inc. (U.S.)
- Merck & Co, Inc. (U.S.)
- Pfizer Inc. (U.S.)
- Novartis AG. (Switzerland)
- AbbVie Inc. (U.S.)
- Astellas Pharma Inc. (Japan)
- AstraZeneca (U.K.)
- Auritec Pharmaceuticals Inc. (U.S.)
- Bayer AG (Germany)
- Chimerix Inc. (U.S.)
- Research Methodology
- Key Assumptions and Acronyms
- GlaxoSmithKline Plc (U.K.)
- Johnson & Johnson Services, Inc. (U.S.)
- Merck & Co, Inc. (U.S.)
- Pfizer Inc. (U.S.)
- Novartis AG. (Switzerland)
- AbbVie Inc. (U.S.)
- Astellas Pharma Inc. (Japan)
- AstraZeneca (U.K.)
- Auritec Pharmaceuticals Inc. (U.S.)
- Bayer AG (Germany)
- Modified Polymer Components, Inc. (Bristol-Myers Squibb) (U.S.)
- Chimerix Inc. (U.S.)
- Eli Lilly and Company (U.S.)
- Isis Pharmaceuticals (U.S.)
- Mitsubishi Chemical Holdings Corporation (Mitsubishi Tanabe Pharma) (Japan)
- Sanofi S.A. (France)
- Gilead Sciences (U.S.)